MIAMI--(BUSINESS WIRE)--Lifeline Pharmaceuticals, a Florida-based pharmaceutical wholesale distribution company, announced today the culmination of its third annual fundraising effort to raise money and awareness for the Juvenile Diabetes Research Foundation (JDRF). JDRF is the leading global organization funding type 1 diabetes (T1D) research and has invested more than $2 billion in research funding since its inception.
In support of JDRF’s mission, Lifeline decided in 2015 to host a series of activities, including a run, to raise funds through the participation of employees, their friends and family members. In all, more than $15,000 has been raised since inception in an effort to find a cure for Type 1 diabetes.
“This is the third year of this campaign that not only raises funds for JDRF, but promotes overall health and the camaraderie of our immediate and our extended Lifeline family,” said Rick Nielsen, President & CEO of Lifeline. “We are honored to raise these funds for JDRF in the name of Cole Cawley, a brave 8 year-old and member of our extended Lifeline family who is courageously dealing with this illness. Lifeline will continue to support Cole and JDRF with these activities and build on them to attract greater numbers of participants to this cause in the future,” concluded Nielsen.
A link to this year’s run can be found here http://lifelinepharm.com/wp-content/uploads/2014/01/JDRF-720.mp4
A link to Lifeline’s video can be found here http://lifelinepharm.com/wp-content/uploads/2014/01/FINALE+SEQUENCE++W+Client+revs+WMV+6000Kbps+720p-HD1.mp4?_=1
About Lifeline Pharmaceuticals:
Lifeline Pharmaceuticals is a nationally certified Minority Business Enterprise (MBE) engaged in the nationwide distribution of pharmaceuticals and is the largest independent pharmaceutical wholesaler of brand and generic injectables in the Southeastern United States. Lifeline is an Authorized Distributor of Record (ADR) for many major pharmaceutical brands, and is committed to the safe and ethical distribution of pharmaceutical products.
Lifeline Pharmaceuticals’ product lines include controlled medications, medical-surgical products, surgical-related injectables, specialty pharmaceuticals, chemotherapy products, vaccines and other specialty injectables.
Lifeline Pharmaceuticals is GDP and Track and Trace compliant, FDA-registered, duly licensed by all state and federal authorities and is headquartered in Florida, with locations in the U.S. Virgin Islands and Mississippi. For more information visit www.lifelinepharm.com.